References
- Degasperi E, Aghemo A, Colombo M. Treatment of extrahepatic manifestations of hepatitis C virus. Clin Liver Dis. 2017; 21:631–643.
- Boglione L, Cusato J, Pinna SM, et al. Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens. Arch Virol. 2018;163:961–967.
- Gragnani L, Visentini M, Fognani E, et al. Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia. Hepatology. 2016; 64:1473–1482.
- Bonnaci M, Lens S, Londono MC, et al. Virologic, clinical, and immune response outcomes of patients with hepatitis C virus-associated cryoglobulinemia treated with direct-acting antivirals. Clin Gastroenterol Hepatol. 2017;15:575–583.
- Negro F, Forton D, Craxi A, et al. Reviews in basic and clinical gastroenterology and hepatology. Gastroenterology.2.
- Dammacco F, Racanelli V, Russi S, et al. The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review. Clin Exp Med. 2016;1:10. doi: 10.1007/s10238-016-0410-9.
- Levine JW, Gota C, Fessler BJ, et al. Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus. J Rheumatol. 2005;32:1164–1167.
- Landau D-A, Saadoun D, Halfon P, et al. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Arthritis Rheum. 2008;58:604–611.
- Chowdhury R, Tsen A. Recurrent mixed cryoglobulinemia despite sustained virologic response to treatment: a case report. Am J Kidney Dis. 2017;70:301–304.
- Gragnani L, Fognani E, Piluso A, et al. Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study. Hepatology. 2015; 61:1145–1153.